EMASS taps DigiKey to expand ECS-DoT-22 global distribution
EMASS has added DigiKey as a global distributor for its ECS-DoT-22 edge AI evaluation board, giving engineers worldwide faster access to the ultra-low-power development hardware. The move is designed to broaden adoption of always-on, on-device AI in battery-powered products like wearables, smart home devices and industrial IoT systems.
Why it matters: - DigiKey gives EMASS a global sales channel that reaches more than one million engineers, designers, makers and procurement professionals each year. - Wider distribution can speed adoption of the ECS-DoT-22-EVB among teams building always-on AI into battery-powered devices. - The board targets applications where power use is a hard constraint, including wearables, hearables, smart home devices, asset trackers and industrial IoT systems.
What happened: - EMASS announced that DigiKey is now a global distributor for EMASS. - The ECS-DoT-22 evaluation board, part number ECS-DoT-22-EVB, is now available to order from DigiKey. - The announcement was made Nov. 10, 2026. - EMASS is a Nanoveu subsidiary focused on ultra-efficient edge AI semiconductor technology.
The details: - DigiKey adds a self-serve path for engineers to get ECS-DoT-22 development hardware onto their bench. - EMASS says the DigiKey listing complements its direct sales team, manufacturer sales representatives and regional distribution partners. - DigiKey offers more than 17.4 million components from over 3,000 manufacturers and ships worldwide. - The ECS-DoT-22-EVB pairs the ECS-DoT-22 edge AI system-on-chip with power, clock, UART/JTAG debug and sensor interfaces. - The board also includes compact board-to-board connectors for adding peripheral sensor boards. - ECS-DoT-22 processes vision, audio, motion and environmental data on a single milliwatt-class platform. - The chip acts as an always-on AI gatekeeper that wakes the host processor only when a meaningful event is detected. - EMASS provides an integrated development environment that gives developers a toolchain for software development and AI model work out of the box. - Scott Smyser, vice president of sales and marketing at EMASS, said customers are already designing ECS-DoT-22 into real products and demand is growing. - Smyser said developers anywhere in the world can now order an ECS-DoT-22-EVB, receive it quickly and start evaluating always-on AI against their own sensors and power budget. - For technical questions, design support or volume inquiries, EMASS directs customers to Scott Smyser at scott@nanoveu.com. - More information is available at the ECS-DoT platform page.
Between the lines: - The DigiKey relationship puts EMASS alongside the sensors, microcontrollers and wireless modules engineers already source during early design work. - The move appears aimed at shortening the path from concept to prototype by placing ECS-DoT-22 hardware in a familiar procurement channel. - EMASS is using distribution reach to reinforce a broader pitch: always-on AI without sacrificing battery life.
What's next: - EMASS said engineers can now order the evaluation board through DigiKey and begin testing their own sensor and power setups. - The company is positioning the platform for further design-ins across wearables, healthcare devices, drones and industrial IoT systems. - EMASS will continue supporting technical questions, design reviews and volume opportunities through its sales contact.
The bottom line: - EMASS is betting that easier global access to its evaluation board will convert interest in ultra-low-power edge AI into more design wins.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Global Healthcare Today
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.